Surfactant administration via thin catheter (S‐TC) vs surfactant administration through an endotracheal tube (S‐ETT)
Death or bronchopulmonary dysplasia at 36 weeks PMA · preterm infants with or at risk of respiratory distress syndrome
Surfactant administration via thin catheter (S‐TC) probably leads to lower death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual… compared with surfactant administration through an endotracheal tube (S‐ETT) (moderate certainty).
1 finding from 1 review
- Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome 2021 · Cochrane Headline outcomes onlyRR 0.59 [0.48, 0.73]10 studies · 1324 participantsModerate